Apoptosis, Fibrosis and Senescence
Nephron Clinical Practice · 24.09.2014 · 127 (1-4) · 65-69
DOI: 10.1159/000363717 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nephron Clinical Practice, online erschienen am 24.09.2014. Verfasst von Didier Portilla. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, University of Virginia, Charlottesville, Va., USA. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Fibrosis is a major hallmark of progressive kidney disease. The cellular mechanisms that lead to kidney tissue fibrosis are complex and include, for example, increased inflammation, increased oxidative stress, and proximal tubule cell death in the form of apoptosis or senescence. Recent studies have identified TWEAK, a tumor necrosis factor-like weak inducer of apoptosis, as a novel cytokine that mediates kidney inflammation in models of renal fibrosis. Inhibition of apoptosis via TWEAK inhibition has been shown to reduce kidney fibrosis. Recent studies using lineage tracing suggest that interstitial pericytes/perivascular fibroblasts differentiate into myofibroblasts and undergo proliferative expansion during fibrosis. Furthermore, increased expression of nuclear peroxisome proliferator-activated receptor-α in proximal tubules can directly reduce increased expression of transforming growth factor-β1 and interstitial inflammation in models of renal fibrosis, which suggests preservation of proximal tubule cell metabolism and integrity represents an important new therapeutic target. In this review, the current evidence and potential molecular mechanisms involved in the development of kidney fibrosis are discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Department of Internal Medicine, University of Virginia, Charlottesville, Va., USA.
Förderung
- NIDDK NIH HHS
Zitieren
APA
Portilla, D. (2014). Apoptosis, Fibrosis and Senescence. Nephron Clinical Practice, 127(1-4), 65-69. https://doi.org/10.1159/000363717
Vancouver
Portilla D. Apoptosis, Fibrosis and Senescence. Nephron Clinical Practice. 2014;127(1-4):65-69. doi:10.1159/000363717
BibTeX
@article{Portilla2014,
author = {Portilla, Didier},
title = {Apoptosis, Fibrosis and Senescence},
journal = {Nephron Clinical Practice},
year = {2014},
volume = {127},
number = {1-4},
pages = {65--69},
doi = {10.1159/000363717}
}
EUVIMED